肝肾肿瘤合并布-加综合症的介入治疗  

Interventional therapy in Budd-Chiari syndrome following liver cancer or renal cancer

作　　者：张延伟[1] 苌英利 薛春晓 曹喜才 李建华 李斌 徐晓冉[2] 

机构地区：[1]广州中医药大学第一附属医院放射科,广东广州510405 [2]河北石家庄钢铁股份有限公司职工医院 [3]天津医科大学总医院

出　　处：《中国医学影像技术》2004年第z2期105-106,共2页Chinese Journal of Medical Imaging Technology

摘　　要：目的　探讨介入治疗在肝肾肿瘤合并布 加综合症中的应用价值。方法　肝癌 3例 ,肾癌 1例。行单纯溶栓 1例 ,PTA成形术 3例 ,PTA后再植入国产“Z”形自膨胀支架 2例。结果　术后DSA检查原侧枝循环血流明显减少。术后一周左右 ,患者的症状和体征改善明显。术后 6个月彩超随访显示支架均开通良好。结论　血管内溶栓和支架植入术是继发性BCS的首选姑息治疗方法 ,可延长患者生存时间 。Objection To study the role of interventional therapy in patients with Budd-Chiari Syndrome (BSC) following liver cancer or renal cancer. Methods There were 3 liver cancers and 1 renal cancer. We administrated simple thrombolysis in 1 case, percutaneous transluminal angioplasty (PTA) in 3 cases, and PIA+self-expansion stent in 2 cases. Results Collateral circulations were obvionsly reduced after interventional therapy. The signs and symptoms of patients were significantly improved in 1 week. Colorful ultrasound examination showed all stents were still keeping open after 6 months. Conclusion The first therapy of secondary BCS following hepatic or renal tumors were thrombolysis and/or percutanous transcatheter stent placement,which can extend survival and improve the quality of patients.

关 键 词：肝肾肿瘤 布-加综合症 介入治疗 

分 类 号：R815[医药卫生—放射医学]